Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 19 Sep 2023 07:00 CEST |
BIOSENIC | BioSenic publishes new evidence of beneficial effects of arsenic trioxide treatment supporting clinical trial for systemic sclerosis | 20103010 Biotechnology | Other subject |
| 19 Sep 2023 07:00 CEST |
BIOSENIC | BioSenic publie de nouvelles preuves des effets bénéfiques du traitement au trioxyde d’arsenic, étayant un essai clinique dans la sclérose systémique | 20103010 Biotechnology | Other subject |
| 19 Sep 2023 06:30 CEST |
ONWARD MEDICAL | ONWARD® veröffentlicht Halbjahresergebnisse 2023 und letzte Geschäftsentwicklungen | 20101025 Health Services | - |
| 19 Sep 2023 06:30 CEST |
ONWARD MEDICAL | ONWARD® Reports 2023 Half Year Results and Business Update | 20101025 Health Services | - |
| 19 Sep 2023 06:30 CEST |
ONWARD MEDICAL | ONWARD® publie ses résultats semestriels 2023 et fait le point sur son activité | 20101025 Health Services | - |
| 19 Sep 2023 06:30 CEST |
ONWARD MEDICAL | ONWARD® comunica la relazione finanziaria semestrale 2023 e provvede un aggiornamento aziendale | 20101025 Health Services | - |
| 19 Sep 2023 06:30 CEST |
ONWARD MEDICAL | ONWARD® rapporteert 2023 halfjaarresultaten en bedrijfsupdate | 20101025 Health Services | - |
| 18 Sep 2023 18:04 CEST |
GBL | GBL - Transacties op GBL-aandelen 18-09-2023 | 30202000 Diversified Financial Services | Other financial transaction |
| 18 Sep 2023 18:04 CEST |
GBL | GBL - Transactions sur actions propres 18-09-2023 | 30202000 Diversified Financial Services | Other financial transaction |
| 18 Sep 2023 18:03 CEST |
GBL | GBL - Transactions on GBL shares 18-09-2023 | 30202000 Diversified Financial Services | Other financial transaction |
| 18 Sep 2023 08:37 CEST |
TITAN CEMENT | Programme de rachats d'actions | 50101030 Cement | Other subject |
| 18 Sep 2023 08:36 CEST |
TITAN CEMENT | Share buyback programme | 50101030 Cement | Other subject |
| 18 Sep 2023 08:07 CEST |
CRESCENT | GEREGLEMENTEERDE INFORMATIE & openbaarmaking van voorwetenschap: Update eerste semester 2023 en nieuwe bestuurder | 15101010 Telecommunications Equipment | Other subject |
| 18 Sep 2023 08:06 CEST |
CRESCENT | REGULATED INFORMATION and disclosure of foreknowledge: Update first semester 2023 and new director | 15101010 Telecommunications Equipment | Other subject |
| 18 Sep 2023 08:04 CEST |
OXURION | Oxurion Receives First EUR 1 Million under Amended Atlas Funding Program | 20103010 Biotechnology | - |
| 18 Sep 2023 08:02 CEST |
OXURION | Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas | 20103010 Biotechnology | - |
| 18 Sep 2023 08:00 CEST |
OXURION | Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC | 20103010 Biotechnology | - |
| 18 Sep 2023 07:36 CEST |
JENSEN-GROUP | Inkoop eigen aandelen - wekelijkse update | 50204000 Machinery: Industrial | Other subject |
| 18 Sep 2023 07:36 CEST |
JENSEN-GROUP | Share buyback – weekly update | 50204000 Machinery: Industrial | Other subject |
| 15 Sep 2023 22:01 CEST |
CELYAD ONCOLOGY | Celyad Oncology SA: Publication of a Rectified Transparency Notification Received From Fortress Investment Group LLC | 20103010 Biotechnology | Other subject |
| 15 Sep 2023 22:01 CEST |
CELYAD ONCOLOGY | Celyad Oncology SA : Publication d’une notification de transparence rectifiée de Fortress Investment Group LLC | 20103010 Biotechnology | Other subject |
| 15 Sep 2023 18:11 CEST |
FAGRON | Progress share buy-back program Fagron | 20102010 Medical Equipment | Other subject |
| 15 Sep 2023 18:11 CEST |
FAGRON | Voortgang aandeleninkoopprogramma Fagron | 20102010 Medical Equipment | Other subject |
| 15 Sep 2023 08:15 CEST |
BEKAERT | Bekaert - Update on the Share Buyback Program | 55102010 Iron and Steel | Legal |
| 15 Sep 2023 08:15 CEST |
BEKAERT | Bekaert - Mise à jour relative au Programme de Rachat d’Actions | 55102010 Iron and Steel | Legal |
| 15 Sep 2023 08:15 CEST |
BEKAERT | Bekaert - Update over het Inkoopprogramma van Eigen Aandelen | 55102010 Iron and Steel | Legal |
| 15 Sep 2023 07:00 CEST |
ARGENX SE | argenx Announces Positive CHMP Opinion for Subcutaneous Efgartigimod for Generalized Myasthenia Gravis | 20103010 Biotechnology | Other subject |
| 14 Sep 2023 18:30 CEST |
ABO GROUP ENVIRONMENT | ABO-Group Environment Half-Year Results 2023 | 50101015 Engineering and Contracting Services | New |
| 14 Sep 2023 18:30 CEST |
ABO GROUP ENVIRONMENT | ABO-Group Environment Chiffres Semestriels 2023 | 50101015 Engineering and Contracting Services | New |
| 14 Sep 2023 18:30 CEST |
ABO GROUP ENVIRONMENT | ABO-Group Environment Halfjaarcijfers 2023 | 50101015 Engineering and Contracting Services | New |
| 14 Sep 2023 18:09 CEST |
VAN DE VELDE | VAN DE VELDE : acquisition of treasury shares | 40204020 Clothing and Accessories | Other subject |
| 14 Sep 2023 18:08 CEST |
GBL | GBL - Transparantieverklaring | 30202000 Diversified Financial Services | Legal |
| 14 Sep 2023 18:07 CEST |
GBL | GBL - Déclaration de transparence | 30202000 Diversified Financial Services | Legal |
| 14 Sep 2023 18:07 CEST |
VAN DE VELDE | VAN DE VELDE : inkoop eigen aandelen | 40204020 Clothing and Accessories | Other subject |
| 14 Sep 2023 18:06 CEST |
GBL | GBL - Transparency declaration | 30202000 Diversified Financial Services | Legal |
| 14 Sep 2023 16:00 CEST |
AZELIS GROUP NV | Azelis Appoints Evy Hellinckx as New CEO for EMEA | 55201000 Chemicals: Diversified | Journal / appointments |
| 14 Sep 2023 07:00 CEST |
BIOSENIC | BioSenic reaches agreement on binding term sheets with main creditors to restructure past financial debts | 20103010 Biotechnology | Alliances and agreements |
| 14 Sep 2023 07:00 CEST |
BIOSENIC | BioSenic parvient à un accord de principe liant avec les principaux créanciers afin de restructurer les dettes financières passées | 20103010 Biotechnology | Alliances and agreements |
| 13 Sep 2023 18:40 CEST |
ONWARD MEDICAL | ONWARD® Startet Partnerschaft mit einem von Kriegsbehinderten geführten Unternehmen, um Zugang zum US-Bundesgesundheitsmarkt zu erhalten | 20101025 Health Services | - |
| 13 Sep 2023 18:40 CEST |
ONWARD MEDICAL | ONWARD® Launches Partnership with Service-Disabled Veteran-Owned Business to Access U.S. Federal Health Market | 20101025 Health Services | - |
| 13 Sep 2023 18:40 CEST |
ONWARD MEDICAL | ONWARD® lance un partenariat avec une entreprise appartenant à des anciens combattants handicapés pour accéder au marché fédéral américain de la santé | 20101025 Health Services | - |
| 13 Sep 2023 18:40 CEST |
ONWARD MEDICAL | ONWARD® Lanceert partnerschap met bedrijven met een handicap die eigendom zijn van veteranen om toegang te krijgen tot de Amerikaanse federale gezondheidszorgmarkt | 20101025 Health Services | - |
| 13 Sep 2023 18:13 CEST |
VIOHALCO | ElvalHalcor, filiale de Viohalco, présente à la Bourse d’Athènes les résultats financiers du premier semestre 2023 | 55102015 Metal Fabricating | Commercial results |
| 13 Sep 2023 18:11 CEST |
VIOHALCO | Viohalco’s subsidiary, ElvalHalcor today submits its H1 2023 financial results to the Athens Stock Exchange | 55102015 Metal Fabricating | Commercial results |
| 13 Sep 2023 18:00 CEST |
AZELIS GROUP NV | Azelis: Transparantiekennisgeving | 55201000 Chemicals: Diversified | Other subject |
| 13 Sep 2023 18:00 CEST |
AZELIS GROUP NV | Azelis: Transparency Notification | 55201000 Chemicals: Diversified | Other subject |
| 12 Sep 2023 22:30 CEST |
NYXOAH SA | Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference | 20102010 Medical Equipment | Other subject |
| 12 Sep 2023 22:30 CEST |
NYXOAH SA | Nyxoah Participera à la Conférence Cantor Fitzgerald Global Healthcare | 20102010 Medical Equipment | Other subject |
| 12 Sep 2023 22:01 CEST |
CELYAD ONCOLOGY | Celyad Oncology SA: Publication of a Transparency Notification Received from Tolefi SA | 20103010 Biotechnology | Other subject |
| 12 Sep 2023 22:01 CEST |
CELYAD ONCOLOGY | Celyad Oncology SA : Publication d’une notification de transparence reçue de Tolefi SA | 20103010 Biotechnology | Other subject |